CHD7 and 53BP1 regulate distinct pathways for the re-ligation of DNA double-strand breaks.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
13 11 2020
Historique:
received: 28 10 2019
accepted: 15 10 2020
entrez: 14 11 2020
pubmed: 15 11 2020
medline: 25 11 2020
Statut: epublish

Résumé

Chromatin structure is dynamically reorganized at multiple levels in response to DNA double-strand breaks (DSBs). Yet, how the different steps of chromatin reorganization are coordinated in space and time to differentially regulate DNA repair pathways is insufficiently understood. Here, we identify the Chromodomain Helicase DNA Binding Protein 7 (CHD7), which is frequently mutated in CHARGE syndrome, as an integral component of the non-homologous end-joining (NHEJ) DSB repair pathway. Upon recruitment via PARP1-triggered chromatin remodeling, CHD7 stimulates further chromatin relaxation around DNA break sites and brings in HDAC1/2 for localized chromatin de-acetylation. This counteracts the CHD7-induced chromatin expansion, thereby ensuring temporally and spatially controlled 'chromatin breathing' upon DNA damage, which we demonstrate fosters efficient and accurate DSB repair by controlling Ku and LIG4/XRCC4 activities. Loss of CHD7-HDAC1/2-dependent cNHEJ reinforces 53BP1 assembly at the damaged chromatin and shifts DSB repair to mutagenic NHEJ, revealing a backup function of 53BP1 when cNHEJ fails.

Identifiants

pubmed: 33188175
doi: 10.1038/s41467-020-19502-5
pii: 10.1038/s41467-020-19502-5
pmc: PMC7666215
doi:

Substances chimiques

Chromatin 0
DNA-Binding Proteins 0
LIG4 protein, human 0
RNF8 protein, human 0
TP53BP1 protein, human 0
Tumor Suppressor p53-Binding Protein 1 0
Green Fluorescent Proteins 147336-22-9
RNF168 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
PARP1 protein, human EC 2.4.2.30
Poly (ADP-Ribose) Polymerase-1 EC 2.4.2.30
HDAC1 protein, human EC 3.5.1.98
Histone Deacetylase 1 EC 3.5.1.98
DNA Helicases EC 3.6.4.-
CHD7 protein, human EC 3.6.4.12
Ku Autoantigen EC 4.2.99.-
DNA Ligase ATP EC 6.5.1.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5775

Subventions

Organisme : European Research Council
ID : 714326
Pays : International
Organisme : Medical Research Council
ID : MR/N02155X/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N02155X/1
Pays : United Kingdom

Références

J Cell Biol. 2013 Aug 5;202(3):579-95
pubmed: 23897892
Nature. 2013 Jul 4;499(7456):50-4
pubmed: 23760478
Science. 2009 Sep 4;325(5945):1240-3
pubmed: 19661379
Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506
pubmed: 28512351
Nature. 2016 Aug 4;536(7614):100-3
pubmed: 27462807
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13770-4
pubmed: 19666485
J Cell Biol. 2005 Jul 18;170(2):201-11
pubmed: 16009723
Nature. 2016 Jun 30;534(7609):714-718
pubmed: 27338793
Genes Dev. 2016 May 15;30(10):1138-54
pubmed: 27222516
Nature. 2018 Aug;560(7716):117-121
pubmed: 30022168
Nat Cell Biol. 2019 Mar;21(3):311-318
pubmed: 30804502
EMBO Rep. 2018 Oct;19(10):
pubmed: 30177554
Nat Struct Mol Biol. 2013 Mar;20(3):259-66
pubmed: 23463310
Nat Struct Mol Biol. 2016 Aug;23(8):714-21
pubmed: 27348077
PLoS Genet. 2008 Jun 27;4(6):e1000110
pubmed: 18584027
Cell. 2013 Jun 6;153(6):1394-405
pubmed: 23746849
Mol Cell. 2014 Mar 20;53(6):1053-66
pubmed: 24582501
Cell Rep. 2014 Aug 21;8(4):1049-62
pubmed: 25131201
Oncogene. 2011 May 5;30(18):2135-46
pubmed: 21217779
Mol Cell. 2015 May 7;58(3):468-82
pubmed: 25921070
Nat Struct Mol Biol. 2013 Mar;20(3):317-25
pubmed: 23377543
J Cell Sci. 2013 Feb 15;126(Pt 4):889-903
pubmed: 23264744
Genes Dev. 2015 Jan 15;29(2):197-211
pubmed: 25593309
J Struct Biol. 2013 Dec;184(3):445-53
pubmed: 24145303
Nat Struct Mol Biol. 2010 Sep;17(9):1144-51
pubmed: 20802485
Mol Cell. 2016 Feb 18;61(4):547-562
pubmed: 26895424
Genes Dev. 2017 Feb 1;31(3):260-274
pubmed: 28242625
Cell Rep. 2017 May 30;19(9):1819-1831
pubmed: 28564601
Mol Cell. 2013 Mar 7;49(5):872-83
pubmed: 23333306
EMBO J. 2012 May 30;31(11):2511-27
pubmed: 22531782
Cell. 2006 Dec 29;127(7):1361-73
pubmed: 17190600
Genes Dev. 2011 Apr 1;25(7):685-700
pubmed: 21406551
Genes Dev. 2019 Jun 1;33(11-12):684-704
pubmed: 31048545
Nucleic Acids Res. 2018 Jul 6;46(12):6087-6098
pubmed: 29733391
Mol Biol Cell. 2016 Dec 1;27(24):3791-3799
pubmed: 27733626
Mol Cell. 2019 Jan 17;73(2):212-223.e7
pubmed: 30554942
J Cell Biol. 2006 Mar 13;172(6):823-34
pubmed: 16520385
Genes Dev. 1999 Oct 15;13(20):2633-8
pubmed: 10541549
Trends Genet. 2015 Oct;31(10):600-611
pubmed: 26411921
J Biol Chem. 2016 Jan 22;291(4):1789-802
pubmed: 26559976
Nature. 2010 Feb 18;463(7283):958-62
pubmed: 20130577
Cell Rep. 2016 Oct 11;17(3):783-798
pubmed: 27732854
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Cell. 2012 Aug 17;150(4):697-709
pubmed: 22884692
Nucleic Acids Res. 2017 Dec 15;45(22):12625-12637
pubmed: 29182755
Nature. 2015 Feb 12;518(7538):258-62
pubmed: 25642963
Leuk Res. 2016 Jun;45:14-23
pubmed: 27064363
J Biol Chem. 2008 Nov 28;283(48):33168-74
pubmed: 18826944
Trends Cell Biol. 2016 Jan;26(1):52-64
pubmed: 26437586
EMBO J. 2017 Dec 15;36(24):3634-3649
pubmed: 29079701
Nat Struct Mol Biol. 2009 Sep;16(9):923-9
pubmed: 19680243
Open Biol. 2016 Sep;6(9):
pubmed: 27655732
Nature. 2008 Nov 27;456(7221):529-33
pubmed: 18931658
J Cell Biol. 2010 Sep 6;190(5):741-9
pubmed: 20805320
Nature. 2014 Oct 9;514(7521):228-32
pubmed: 25119037
Nature. 2015 Feb 12;518(7538):254-7
pubmed: 25642960
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 5;372(1731):
pubmed: 28847822
Nat Commun. 2019 Sep 19;10(1):4286
pubmed: 31537809
PLoS Genet. 2011 Jun;7(6):e1002080
pubmed: 21655080
J Med Genet. 2011 May;48(5):334-42
pubmed: 21378379
Nucleic Acids Res. 2016 Feb 29;44(4):1657-68
pubmed: 26578561

Auteurs

Magdalena B Rother (MB)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Stefania Pellegrino (S)

Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.

Rebecca Smith (R)

Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes)-UMR 6290, BIOSIT-UMS3480, F-35000, Rennes, France.

Marco Gatti (M)

Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.

Cornelia Meisenberg (C)

The Institute of Cancer Research, Royal Cancer Hospital, London, UK.

Wouter W Wiegant (WW)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Martijn S Luijsterburg (MS)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Ralph Imhof (R)

Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.

Jessica A Downs (JA)

The Institute of Cancer Research, Royal Cancer Hospital, London, UK.

Alfred C O Vertegaal (ACO)

Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.

Sébastien Huet (S)

Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes)-UMR 6290, BIOSIT-UMS3480, F-35000, Rennes, France.
Institut Universitaire de France, Paris, France.

Matthias Altmeyer (M)

Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland. matthias.altmeyer@uzh.ch.

Haico van Attikum (H)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. h.van.attikum@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH